ReviewFrontiers in pharmacology2022

Synergistic association of resveratrol and histone deacetylase inhibitors as treatment in amyotrophic lateral sclerosis.

Edoardo Parrella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.